Affymetrix to Webcast Presentation at the Lehman Brothers Global Healthcare Conference

Affymetrix to Webcast Presentation at the Lehman Brothers Global
Healthcare Conference 


SANTA CLARA, Calif., March 24  /PRNewswire-FirstCall/ -- Affymetrix, Inc.
(NASDAQ:AFFX) today announced that Greg Schiffman, Executive Vice President and
CFO, will provide a company overview at the Lehman Brothers Global Healthcare
Conference in Miami Beach, Florida. A live transmission of the presentation
will take place at 5:15 PM ET/2:15 PM PT on Thursday, March 31st 2005. An
archived webcast will be available for 30 days.

To access the live webcast or archived presentation, please go to
http://www.affymetrix.com/ and click on the "Investors" link.

About Affymetrix

Affymetrix scientists invented the world's first high-density microarray in
1989 and began selling the first commercial microarray in 1994. Since then,
Affymetrix GeneChip(R) technology has become the industry standard in molecular
biology research. Affymetrix technology is used by the world's top
pharmaceutical, diagnostic and biotechnology companies as well as leading
academic, government and not-for-profit research institutes. More than 1,200
systems have been installed around the world and nearly 3,000 peer-reviewed
papers have been published using the technology. Affymetrix' patented
photolithographic manufacturing process provides the most information capacity
available today on an array, enabling researchers to use a whole-genome
approach to analyze the relationship between genetics and health. Affymetrix is
headquartered in Santa Clara, Calif., with manufacturing facilities in
Sacramento, Calif., and Bedford, Mass. The company maintains important sales
and marketing operations in Europe and Asia and has about 900 employees
worldwide. 

DATASOURCE: Affymetrix, Inc.



CONTACT:  Doug Farrell, Vice President of Investor Relations of

Affymetrix, Inc., [phone]



Web site:  http://www.affymetrix.com/ 

Copyright